We are proud to share our latest review article on #PC111, a fully human anti-Fas Ligand monoclonal antibody, and its potential as a disease-modifying therapy for #pemphigus and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (#SJSTEN).This work highlights how...
A proud milestone for Scinai Immunotherapeutics Ltd. and our partners at PinCell srl. Heartfelt congratulations to Dr. Roberta Lotti of PinCell srl for receiving the “Oscar of Italian Dermatology” from SIDeMaST – Società Italiana di Dermatologia e delle Malattie...
We’re excited to announce a major milestone: the Italian government has granted regulatory clearance under the Golden Power regulation for our planned acquisition of Pincell S.r.l., a pioneering Italian biotech company. “We are pleased to have received this...
I’m honored to have received the “Oscar of Italian Dermatology” from the SIDeMaST – Società Italiana di Dermatologia e delle Malattie Sessualmente Trasmesse, in the category of Immunopathology and Cutaneous Allergies! The awarded paper, “Blocking...
La Repubblica, 08.05.2025 – L’azienda nasce come spin-off dell’Università di Modena e Reggio Emilia e si occupa di ricerca contro il pemfigo e la sindrome di Stevens-Johnson. Download this post in...
